Results 241 to 250 of about 151,127 (351)

Screening for prostatic cancer: the case for. [PDF]

, 1993
Allhoff, E. P., Kuczyk, M., Liedke, S. G., Stief, Christian Georg   +3 more
core   +1 more source

Medicare Reimbursement Trends in Zenker's Diverticulectomy

Laryngoscope Investigative Otolaryngology, Volume 10, Issue 5, October 2025.
ABSTRACT Objective To analyze Medicare reimbursement and utilization trends of Zenker's diverticulectomy from 2000 to 2024. Study Design Retrospective cross‐sectional study. Setting Centers for Medicare and Medicaid Services (CMS) Physician Fee Schedule (2000–2024) and Part B Medicare Fee‐For‐Service National Summary Data (2000–2022).
George S. Bebawy, Aman M. Patel, David Herz, Paul T. Cowan, Andrey Filimonov, Ghayoour S. Mir   +5 more
wiley   +1 more source

Management in robot-assisted radical prostatectomy patients with recto-urethral fistulas: the York-Mason technique. [PDF]

World J Urol
van der Graaf SH, Wit EMK, Beets GL, Grotenhuis BA, Roeleveld TA, Nieuwenhuijzen JA, Vis AN, van Leeuwen PJ, van der Poel HG.   +8 more
europepmc   +1 more source

Targeted Therapies in the Most Common Advanced Solid Tumors, Drug Resistance, and Counteracting Progressive Micrometastatic Disease: The Next Frontier of Research

MedComm, Volume 6, Issue 10, October 2025.
In TME, undetectable DCCs (panel A) join with a low tumor burden along with low immune suppression, that favor successful immune manipulation through immune suppression inhibiting immune‐therapy. This moves the immune balance toward the immune response and likely makes more stable the dormant state of DCCs in the unstable metastatic niche and/or allows
Andrea Nicolini, Paola Ferrari, Roberto Silvestri, Dario A. Bini   +3 more
wiley   +1 more source

Retraction Note: Predictive value of microRNA-133a-3p for early urinary incontinence after radical prostatectomy for prostate cancer and its correlation with rehabilitation effects. [PDF]

Hereditas
Yang F, Qin Q, Liu J.
europepmc   +1 more source

SINGLE INJECTION SPINAL ANAESTHESIA WITH AMETHOCAINE AND MORPHINE FOR TRANSURETHERAL PROSTATECTOMY

, 1983
Aileen Cunningham, Jocelyne McKenna, D. S. Skene   +2 more
openalex   +1 more source

Diagnostic Performance of Prostate Cancer Disease‐Specific Phenotypes Identified Using Real‐World Databases: A Systematic Review

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 10, October 2025.
ABSTRACT Background Research using real‐world databases (RWD) often requires the development of computable phenotypes based on clinical reasoning‐based algorithms or prediction models with validation through a reference standard such as chart review. While there are studies reporting different phenotypes for key prostate cancer (PC) disease or outcomes,
Ami Vyas, Shweta Kamat, Sadie Thomas, Connor Gambino, Britny R. Brown, Amit D. Raval   +5 more
wiley   +1 more source

Bilateral vas deferens suturing to prevent inguinal hernias after radical prostatectomy. [PDF]

BJUI Compass
Hata K, Goto Y, Hashimoto M, Takahashi Y, Takiguchi Y, Iwamoto Y, Saito S, Kawaharada A, Enei Y, Sakanaka K, Takahashi K, Hisakane A, Yamazaki T, Yasue K, Aoki S, Kasai K, Yanagisawa T, Tsuzuki S, Ishii G, Yamamoto T, Sasaki H, Miki J, Shimomura T, Yamada H, Furuta A, Miki K, Kimura T.   +26 more
europepmc   +1 more source

Altered Glycosylation of PSA in Prostate Cancer Tissue

The Prostate, Volume 85, Issue 14, Page 1290-1298, October 2025.
ABSTRACT Background The glycosylation of proteins is commonly altered in cancer. This offers novel opportunities for cancer biomarker development. As prostate‐specific antigen (PSA) is a glycoprotein, identification of cancer‐specific PSA‐glycoforms is feasible. Such PSA‐glycoforms may provide valuable diagnostic and prognostic information. Methods PSA‐
Hannu Koistinen, Ruusu‐Maaria Merivirta, Timo‐Pekka Lehto, Anna Lempiäinen, Andrew Erickson, Ulf‐Håkan Stenman, Antti Rannikko, Tuomas Mirtti   +7 more
wiley   +1 more source

Reduced recurrence of prostate cancer with novel autologous cancer vaccine (FK- PC101) post-prostatectomy: long-term results from a single-center phase 1/2 study. [PDF]

Future Sci OA
Freitas DMO, Stein AC, Berger M, Kreutz FT.   +3 more
europepmc   +1 more source